Clinical Results Obtained with Sublingual Administration of Methyl Testosterone

Publisher Website
Google Scholar
Abstract
A report is made of 19 cases comprising $? varying in age from 27 to 67 yrs., 15 of whom were suffering from climacteric symptoms, 2 from dysmenorrhea and 2 from mastodynia. Methyl testosterone was administered sublingually in dosages varying from 1 tablet of 5 mg. a day . up to 6 tablets a day in severe cases. The prep. was well tolerated, only 1 patient showed any signs of arrhenomi-metic symptoms after having received ,900 mg. In 6 patients with insomnia and hot flashes, one tablet of 5 mg. every day for 2 mos. was sufficient. In 4 patients with pruritis, treatment with 5-6 tablets a day made sleep possible. In one of the 2 cases of dysmenorrhea all forms of treatment failed; in the other, the pains were somewhat alleviated by 6 tablets a day for 3 days before menstruation and 2 days after it had started. In the 2 cases of mastodynia, the pains disappeared within a mo. with a dose of 3-6 tablets a day. Conclusions cannot be made in so small a number of cases but apparently methyl testosterone sublingual tablets constitute an effective and convenient treatment of climacteric deficiency symptoms. The disagreeable effects can be avoided by taking smears regularly.

This publication has 3 references indexed in Scilit: